PMC:7309518 / 0-698
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 540-548 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T2 | 554-559 | Body_part | denotes | nerve | http://purl.org/sig/ont/fma/fma65132 |
| T3 | 560-571 | Body_part | denotes | glycolipids | http://purl.org/sig/ont/fma/fma82780 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 554-559 | Body_part | denotes | nerve | http://purl.obolibrary.org/obo/UBERON_0001021 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 0-23 | Disease | denotes | Guillain-Barré syndrome | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T2 | 46-54 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 76-94 | Disease | denotes | neurologic disease | http://purl.obolibrary.org/obo/MONDO_0005071 |
| T4 | 113-121 | Disease | denotes | myositis | http://purl.obolibrary.org/obo/MONDO_0008054|http://purl.obolibrary.org/obo/MONDO_0021167 |
| T6 | 171-179 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T7 | 191-194 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T8 | 227-245 | Disease | denotes | autoimmune disease | http://purl.obolibrary.org/obo/MONDO_0007179 |
| T9 | 280-288 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T10 | 397-400 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T11 | 419-427 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T12 | 591-599 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T13 | 610-641 | Disease | denotes | autoimmune necrotizing myositis | http://purl.obolibrary.org/obo/MONDO_0016098 |
| T14 | 633-641 | Disease | denotes | myositis | http://purl.obolibrary.org/obo/MONDO_0008054|http://purl.obolibrary.org/obo/MONDO_0021167 |
| T16 | 643-646 | Disease | denotes | NAM | http://purl.obolibrary.org/obo/MONDO_0009722|http://purl.obolibrary.org/obo/MONDO_0016098 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 146-155 | http://purl.obolibrary.org/obo/BFO_0000030 | denotes | Objective |
| T2 | 554-559 | http://purl.obolibrary.org/obo/UBERON_0001021 | denotes | nerve |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 540-548 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T2 | 560-571 | Chemical | denotes | glycolipids | http://purl.obolibrary.org/obo/CHEBI_33563 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2 | 46-54 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3 | 65-94 | Disease | denotes | autoimmune neurologic disease | MESH:D020274 |
| 7 | 171-179 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 8 | 227-245 | Disease | denotes | autoimmune disease | MESH:D001327 |
| 9 | 280-288 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 15 | 419-427 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 16 | 528-533 | Disease | denotes | COVID | MESH:C000657245 |
| 17 | 591-599 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 18 | 610-641 | Disease | denotes | autoimmune necrotizing myositis | MESH:D020721 |
| 19 | 652-668 | Disease | denotes | encephalopathies | MESH:D001927 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-24 | Sentence | denotes | Guillain-Barré syndrome: |
| T2 | 25-94 | Sentence | denotes | The first documented COVID-19–triggered autoimmune neurologic disease |
| T3 | 95-135 | Sentence | denotes | More to come with myositis in the offing |
| T4 | 137-145 | Sentence | denotes | Abstract |
| T5 | 146-155 | Sentence | denotes | Objective |
| T6 | 156-380 | Sentence | denotes | To present the COVID-19–associated GBS, the prototypic viral-triggered autoimmune disease, in the context of other emerging COVID-19–triggered autoimmunities, and discuss potential concerns with ongoing neuroimmunotherapies. |
| T7 | 382-389 | Sentence | denotes | Methods |
| T8 | 390-572 | Sentence | denotes | Eleven GBS cases in four key COVID-19 hotspots are discussed regarding presenting symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 113-121 | Phenotype | denotes | myositis | http://purl.obolibrary.org/obo/HP_0100614 |
| T2 | 227-245 | Phenotype | denotes | autoimmune disease | http://purl.obolibrary.org/obo/HP_0002960 |
| T3 | 299-313 | Phenotype | denotes | autoimmunities | http://purl.obolibrary.org/obo/HP_0002960 |
| T4 | 633-641 | Phenotype | denotes | myositis | http://purl.obolibrary.org/obo/HP_0100614 |
| T5 | 652-668 | Phenotype | denotes | encephalopathies | http://purl.obolibrary.org/obo/HP_0001298 |